These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6794925)

  • 21. 7,8-Benzoflavone stimulates the metabolic activation of aflatoxin B1 to mutagens by human liver.
    Buening MK; Fortner JG; Kappas A; Corney AH
    Biochem Biophys Res Commun; 1978 May; 82(1):348-55. PubMed ID: 352361
    [No Abstract]   [Full Text] [Related]  

  • 22. Differences in aflatoxin B1-susceptibility of rat and mouse are correlated with the capability in vitro to inactivate aflatoxin B1-epoxide.
    Degen GH; Neumann HG
    Carcinogenesis; 1981; 2(4):299-306. PubMed ID: 6791853
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of phenobarbital pretreatment on the metabolism and toxicokinetics of aflatoxin B1 in the rhesus monkey.
    Wong ZA; Wei CI; Rice DW; Hsieh DP
    Toxicol Appl Pharmacol; 1981 Sep; 60(3):387-97. PubMed ID: 6794183
    [No Abstract]   [Full Text] [Related]  

  • 24. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals.
    Zeiger E; Anderson B; Haworth S; Lawlor T; Mortelmans K
    Environ Mol Mutagen; 1988; 11 Suppl 12():1-157. PubMed ID: 3277844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis.
    Essigmann JM; Croy RG; Bennett RA; Wogan GN
    Drug Metab Rev; 1982; 13(4):581-602. PubMed ID: 6813091
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduced levels of mutagen processing potential in the Schistosoma japonicum-infected mouse liver.
    Matsuoka H; Aji T; Ishii A; Arimoto S; Wataya Y; Hayatsu H
    Mutat Res; 1989 Nov; 227(3):153-7. PubMed ID: 2509904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modified mutagen metabolism in Schistosoma hematobium-infested organisms.
    Gentile JM; Brown S; Aardema M; Clark D; Blankespoor H
    Arch Environ Health; 1985; 40(1):5-12. PubMed ID: 3922319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of incubation and activation conditions on the hepatocyte-mediated plate incorporation and preincubation Salmonella typhimurium mutagenesis assays.
    Williams K; Inmon J; Lewtas J
    Teratog Carcinog Mutagen; 1983; 3(4):367-76. PubMed ID: 6138869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism, covalent binding, and mutagenicity of aflatoxin B1 by liver extracts from rats of various ages.
    Jayaraj A; Hardwick JP; Diller TW; Richardson AG
    J Natl Cancer Inst; 1985 Jan; 74(1):95-103. PubMed ID: 3918213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modifying role of dietary factors on the mutagenicity of aflatoxin B1: in vitro effect of sulphur-containing amino acids.
    Shetty TK; Francis AR; Bhattacharya RK
    Mutat Res; 1989 Apr; 222(4):403-7. PubMed ID: 2495441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic activation of carcinogens in the Salmonella mutagenicity assay by hamster and rat liver S-9 preparations.
    Raineri R; Poiley JA; Pienta RJ; Andrews AW
    Environ Mutagen; 1981; 3(1):71-84. PubMed ID: 7021144
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies.
    Groopman JD; Haugen A; Goodrich GR; Wogan GN; Harris CC
    Cancer Res; 1982 Aug; 42(8):3120-4. PubMed ID: 6807538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study on the metabolism and activation of aflatoxin B1 in nuclet, microsomes and reconstituted P-450 system of rat liver.
    Ueno Y; Yoshizawa H; Uchimaru R
    Dev Toxicol Environ Sci; 1980; 8():279-82. PubMed ID: 6796374
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic activation of hepatocarcinogens in chronic hepatitis B.
    De Flora S; Romano M; Basso C; Serra D; Astengo M; Picciotto A
    Mutat Res; 1985 Nov; 144(3):213-9. PubMed ID: 3932846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test system: metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster, and man.
    Wirth PJ; Dybing E; von Bahr C; Thorgeirsson SS
    Mol Pharmacol; 1980 Jul; 18(1):117-27. PubMed ID: 6997726
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship between vitamin A dietary intake and mutagenic activity of some chemical carcinogens.
    Cassand P; Leveque F; Decoudu S; Narbonne JF
    Food Addit Contam; 1990; 7 Suppl 1():S58-9. PubMed ID: 2124552
    [No Abstract]   [Full Text] [Related]  

  • 37. Interindividual differences in the activation of two hepatic carcinogens to mutagens by human liver.
    Harries GC; Boobis AR; Collier N; Davies DS
    Hum Toxicol; 1986 Jan; 5(1):21-6. PubMed ID: 3081427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of lysis in lysogenic bacteria by liver microsomal metabolites of aflatoxin B1.
    Buch JK; Dave PJ
    Indian J Exp Biol; 1980 Oct; 18(10):1162-4. PubMed ID: 6783510
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative biotransformation of aflatoxin B1 in mammalian airway epithelium.
    Ball RW; Coulombe RA
    Carcinogenesis; 1991 Feb; 12(2):305-10. PubMed ID: 1899809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
    Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
    J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.